Cresset Asset Management’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-14,086
Closed -$108K – 2111
2024
Q3
$108K Sell
14,086
-1,197
-8% -$11K ﹤0.01% 2038
2024
Q2
$158K Sell
15,283
-1,878
-11% -$20.6K ﹤0.01% 1918
2024
Q1
$205K Sell
17,161
-2,305
-12% -$25.6K ﹤0.01% 1764
2023
Q4
$210K Buy
19,466
+1,213
+7% +$14.7K ﹤0.01% 1679
2023
Q3
$253K Buy
18,253
+4,973
+37% +$72.7K ﹤0.01% 1511
2023
Q2
$159K Buy
+13,280
New +$150K ﹤0.01% 1773
2019
Q2
– Sell
-152
Closed -$2K – 1382
2019
Q1
$2K Buy
152
+52
+52% +$682 ﹤0.01% 1678
2018
Q4
$1K Buy
+100
New +$1.47K ﹤0.01% 1563

Other funds holding PTEN

Cresset Asset Management's PTEN Position: Q4 2024 in Review

Cresset Asset Management sold out of Patterson-UTI (PTEN) in Q4 2024, closing a stake of 14,086 shares — an estimated $108K sold.

Cresset Asset Management first reported a position in PTEN in Q4 2018 and held it in 8 quarters. The position peaked at $253K in Q3 2023. 365 funds tracked by Wall St. Rank hold PTEN as of Q4 2024.

  • Cresset Asset Management reported no remaining Patterson-UTI position as of Q4 2024 after selling out during the quarter.
  • Cresset Asset Management sold 14,086 Patterson-UTI shares in Q4 2024, an estimated $108K.
  • Cresset Asset Management first reported a position in Patterson-UTI in Q4 2018 and held it in 8 quarters.
  • Cresset Asset Management's Patterson-UTI position peaked at $253K in Q3 2023.
  • 365 funds tracked by Wall St. Rank held Patterson-UTI as of Q4 2024.

Based on Cresset Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.